Go Hubei || Annoroad helped launch Hubei Province's prenatal screening program in the post-COVID-19 period

Annoroad, as an international leading provider of NIPT testing services and reagents, has officially undertaken the free non-invasive prenatal DNA testing activities proposed by China Maternal and Child Health Association for people related to the COVID-19 pandemic in Hubei.


The Novel Coronavirus pandemic that broke out at the end of 2019 was a global public health emergency. Hubei Province, as the front line of China's fight against COVID-19, had the largest number of confirmed patients nationwide. The people and medical workers in Hubei province made great efforts to fight the pandemic. However, pregnant women during and after  the fight against pandemic were under physical and psychological pressures from both fighting the pandemic and their pregnancy. Some pregnant women even missed the best time for Down's screening, affecting the health of both expectant mothers and fetuses. Therefore, it is more urgent to pay attention to the mental and physical health of patients diagnosed with COVID-19 and first-line anti-pandemic medical workers who are pregnant.

On May 21, 2020, the China Maternal and Child Health Association officially issued a document announcing the launch of a public welfare activity for free non-invasive prenatal DNA testing for front-line medical workers against the COVID-19 and for pregnant women with a history of Novel Coronavirus infection in Hubei Province. Women from Hubei who became pregnant from January 1, 2020 to December 31, 2020 can participate in the activity if they meet one of the following two conditions:

1. The pregnant woman or her husband has a past/present diagnosis of Novel Coronavirus infection;

2. The pregnant woman herself is a medical worker on the front line of the COVID-19 response.

The China Maternal and Child Health Association actively responds to the national call to increase the care towards people fighting against COVID-19, and thus organizes this public welfare project aiming to bring warmth to Novel Coronavirus infected patients and front-line medical workers through a three-level service network covering the whole province. In addition, by virtue of the new non-invasive prenatal DNA testing, the mental and physical health of pregnant women in Hubei Province during the post-pandemic period can be guaranteed, thus promoting prenatal and postnatal care. As a well-known company in China's genome industry, Annoroad has always paid close attention to maternal health and pandemic situation, fully cooperated with the disease prevention and control work of the government and medical departments, and actively fulfilled its social responsibilities.

Annoroad provides sequencing clinical testing services covering the full life cycle and full birth cycle, including non-invasive prenatal DNA testing and upgrading programs, which have become a star series of reproductive lines. Those star programs have been on the market for eight years with three versions, i.e., non-invasive prenatal DNA testing, non-invasive Annoroad, and non-invasive Annoroad 2.0, suitable for meeting the diverse and personalized needs of expectant mothers. (For more details, please click: What about non-invasive Series?


Copyright © Annoroad Gene Technology 京ICP备12029022号-1